Search Results 1-10 of 17372 for GLP-1 secretion

  1. Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes - Mayo Clinic

    The purpose of this study is to determine the effect of endogenous GLP-1 secretion on islet function in people with Typr 2 Diabetes Mellitus (T2DM). GLP-1 ...

  2. Contribution of GLP-1 Receptor - Mayo Clinic

    The GLP-1 receptor gene is found on the beta cells of the pancreas. Its role is in the control of blood sugar level by enhancing insulin secretion from the ...

  3. Effect Of Fasting, Endogenous GLP-1 Secretion On B-cell Response To Intravenous Glucose - Mayo Clinic

    The purpose of this study is to determine the effect of GLP-1 in priming β-cells for insulin secretion. Participation eligibility. Participant eligibility ...

  4. Diabetes drugs and weight loss - Mayo Clinic

    The first group is glucagon-like peptide 1 (GLP-1) agonists. ... Exenatide extended release (Bydureon BCise). ... Gastric Bypass Surgery: One Patient's Journey ...

  5. The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass - Mayo Clinic

    The hypothesis of this study is that increased glucagon-like peptide-1 (GLP-1) secretion explains the amelioration in insulin secretion after Roux-en-Y Gastric ...

  6. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor ...

  7. Adrian Vella, M.D. - Mayo Clinic Faculty Profiles

    Effects of GLP-1 on glucose metabolism. Glucagon-like peptide 1 (GLP-1) is an incretin hormone that powerfully stimulates insulin secretion. Various ...

  8. Gastric Bypass Clinical Trials - Mayo Clinic Research

    The hypothesis of this study is that increased glucagon-like peptide-1 (GLP-1) secretion explains the amelioration in insulin secretion after Roux-en-Y Gastric ...

  9. Gastric Bypass (Roux-En-Y) Clinical Trials - Mayo Clinic Research

    The hypothesis of this study is that increased glucagon-like peptide-1 (GLP-1) secretion explains the amelioration in insulin secretion after Roux-en-Y Gastric ...

  10. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    The purpose of this study is determine the effect of β-cell function and glycemic control on islet GLP-1. Participation eligibility. Participant eligibility ...